✦ LIBER ✦

Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma

✍ Scribed by Michelle Fanale; Luis Fayad; Barbara Pro; Felipe Samaniego; Mary Joy Liboon; Cesar Nunez; Sandra Horowitz; Paolo Anderlini; Uday Popat; Yuan Ji; Larry W. Kwak; Anas Younes

Book ID: 108677200
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 88 KB
Volume: 154
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2011.08618.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I safety study of enzastaurin pl

A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma

✍ Irene M. Ghobrial; Nikhil C. Munshi; Brianna N. Harris; Peipei Shi; Nichole M. P 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

Phase I trial of fludarabine, bortezomib

Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma

✍ Paul M. Barr; Pingfu Fu; Hillard M. Lazarus; Nancy Horvath; Stanton L. Gerson; O 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Phase I study of anti-CD22 immunoconjuga

Phase I study of anti-CD22 immunoconjugate inotuzumab ozogamicin plus rituximab in relapsed/refractory B-cell non-Hodgkin lymphoma

✍ Michinori Ogura; Kiyohiko Hatake; Kiyoshi Ando; Kensei Tobinai; Kota Tokushige; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB

Phase II study of elsamitrucin (BMY-2809

Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphoma

✍ S. L. Allen; L. P. Schacter; S. M. Lichtman; R. Bukowski; D. Fusco; M. Hensley; 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 351 KB

Phase I/II trial assessing bendamustine

Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma

✍ Berenson, James R.; Yellin, Ori; Bessudo, Alberto; Boccia, Ralph V.; Noga, Steph 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

Phase II trial of denileukin diftitox fo

Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma

✍ Nam H. Dang; Barbara Pro; Fredrick B. Hagemeister; Felipe Samaniego; Dan Jones; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB